State Street
AURA icon

State Street’s Aura Biosciences AURA Stock Holding History

State Street’s Portfolio AURA Stock Details AURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$14.5M Buy
2,301,520
+1,078,536
+88% +$7.71M ﹤0.01% 2531
2026
Q2 		$8.68M Buy
1,222,984
+258,314
+27% +$1.85M ﹤0.01% 2799
2026
Q1 		$6.45M Buy
964,670
+38,136
+4% +$219K ﹤0.01% 2832
2025
Q4 		$5.05M Buy
926,534
+47,663
+5% +$283K ﹤0.01% 2989
2025
Q3 		$5.43M Buy
878,871
+22,685
+3% +$148K ﹤0.01% 2972
2025
Q2 		$5.36M Buy
856,186
+63,175
+8% +$369K ﹤0.01% 2913
2025
Q1 		$4.65M Sell
793,011
-8,812
-1% -$66.7K ﹤0.01% 2906
2024
Q4 		$6.59M Buy
801,823
+47,020
+6% +$443K ﹤0.01% 2836
2024
Q3 		$6.73M Buy
754,803
+26,841
+4% +$230K ﹤0.01% 2817
2024
Q2 		$5.5M Buy
727,962
+158,158
+28% +$1.16M ﹤0.01% 2888
2024
Q1 		$4.47M Buy
569,804
+63,542
+13% +$527K ﹤0.01% 2972
2023
Q4 		$4.49M Buy
506,262
+48,902
+11% +$414K ﹤0.01% 2998
2023
Q3 		$4.1M Buy
457,360
+4,093
+0.9% +$44K ﹤0.01% 3019
2023
Q2 		$5.6M Buy
453,267
+104,712
+30% +$1.12M ﹤0.01% 2941
2023
Q1 		$3.23M Buy
348,555
+37,865
+12% +$393K ﹤0.01% 3150
2022
Q4 		$3.26M Buy
310,690
+12,252
+4% +$156K ﹤0.01% 3226
2022
Q3 		$5.41M Buy
298,438
+41,692
+16% +$631K ﹤0.01% 3020
2022
Q2 		$3.64M Buy
256,746
+171,764
+202% +$2.84M ﹤0.01% 3252
2022
Q1 		$1.87M Buy
84,982
+37,797
+80% +$720K ﹤0.01% 3596
2021
Q4 		$801K Buy
+47,185
New +$843K ﹤0.01% 3865

Other funds holding AURA

Medicxi Ventures Management
Medicxi Ventures Management St. Helier, Jersey $127M AUM 21.77% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $474B AUM 32.39% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Levin Capital Strategies
Levin Capital Strategies New York $1.42B AUM 19.05% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Regency Capital Management
Regency Capital Management Honolulu, Hawaii $247M AUM 24.61% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Y-Intercept (HK)
Y-Intercept (HK) Hong Kong $4.52B AUM 6.6% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $294B AUM 47.59% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $73.4B AUM 32.8% 1-Year Est. Return

State Street's AURA Position: Q3 2026 in Review

State Street increased its Aura Biosciences (AURA) stake by 88% in Q3 2026, buying an estimated $7.71M and bringing the position to 2,301,520 shares worth $14.5M. The position accounts for ﹤0.01% of the portfolio, ranked #2531.

State Street first reported a position in AURA in Q4 2021 and has held it in 20 quarters since. 77 funds tracked by Wall St. Rank hold AURA as of Q3 2026.

  • State Street held 2,301,520 shares of Aura Biosciences worth $14.5M as of Q3 2026.
  • State Street bought 1,078,536 Aura Biosciences shares in Q3 2026, an estimated $7.71M.
  • Aura Biosciences made up ﹤0.01% of State Street's portfolio in Q3 2026, its #2531 holding.
  • State Street first reported a position in Aura Biosciences in Q4 2021 and has held it in 20 quarters since.
  • 77 funds tracked by Wall St. Rank held Aura Biosciences as of Q3 2026.

Based on State Street's 13F filing for Q3 2026, filed 12 Nov 2026.